Market Overview

Cowen: Nike's Chinese Growth Unthreatened By NBA Turmoil

Share:
Cowen: Nike's Chinese Growth Unthreatened By NBA Turmoil

NBA games during the upcoming season could be further restricted in China, but Cowen said it's is skeptical it will materially affect Nike Inc (NYSE: NKE)'s most profitable region.

The Analyst 

John Kernan reiterated an Outperform rating on Nike with a $105 price target.

The Thesis 

It's doutbtful the turmoil between China and the NBA will derail Nike's tremendous growth in the region, as he brand's “strength in the region is substantial,” the analyst said in a note. (See his track record here.)

"Nike has experienced ‘double-digit growth every quarter for more than five years’ in Greater China, ‘works closely’ with China’s Ministry of Sport and Education as Chinese consumers are encouraged to adopt more active lifestyle and the company has been growing its digital presence on Tmall and WeChat while opening its first House Of Innovation in Shanghai in 2018."

At Nike’s Investor Day in 2017, the company set a low-to-mid-teens revenue growth target for Greater China and has exceeded this target every year since, he said. 

Greater China represents 17% of total Nike brand revenue, and Kernan expects the region to comprise 24% of total Nike brand revenue by 2024. 

Powell: Endorsements Matter In China

NPD Group analyst Matt Powell predicts that the fallout between the NBA and China could lead consumers to ditch western footwear companies for local brands, but contends that basketball shoe sales in China have been robust.

“From what I’m seeing, endorsed NBA players still drive sales in China, while they do not in the U.S.,” Powell said in a Thursday blog post. 

Price Action

Nike shares were up 0.95% Friday, closing at $93.88.

Related Links:

Footwear Expert: Tariffs Hurt Nike In A Different Manner Than You Think

Houston Rockets, NBA Face Backlash In China After GM Tweets About Hong Kong Protests

Photo by Wpcpey via Wikimedia

Latest Ratings for NKE

DateFirmActionFromTo
Nov 2019Initiates Coverage OnOverweight
Nov 2019Initiates Coverage OnOutperform
Oct 2019MaintainsOutperform

View More Analyst Ratings for NKE
View the Latest Analyst Ratings

Posted-In: Cowen John KernanAnalyst Color News Price Target Reiteration Global Analyst Ratings Best of Benzinga

 

Related Articles (NKE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NEWCitiUpgrades
BKNGConsumer Edge ResearchInitiates Coverage On2,250.0
EXPEConsumer Edge ResearchInitiates Coverage On100.0
TRIPConsumer Edge ResearchInitiates Coverage On26.0
IAreteInitiates Coverage On39.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

58 Biggest Movers From Friday

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings